Xeris Biopharma Holdings, Inc. (XERS)
7.06
-0.11
(-1.53%)
USD |
NASDAQ |
Dec 15, 16:00
7.06
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Research and Development Expense (Annual): 25.56M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Assertio Holdings, Inc. | 3.822M |
| Amneal Pharmaceuticals, Inc. | 190.71M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |
| Theriva Biologics, Inc. | 12.03M |